Durata Therapeutics

Durata Therapeutics was a clinical development stage company in the pharmaceutical industry which focused on the treatment of infections. On November 17, 2014, the company was acquired by Actavis (now Allergan) for $675 million.

Durata Therapeutics, Inc.
IndustryPharmaceutical industry
Founded2009 (2009)
DefunctNovember 17, 2014 (November 17, 2014)
FateAcquired by Actavis (now Allergan)
HeadquartersMorristown, New Jersey
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.